Results 291 to 300 of about 163,030 (345)

Antithrombotic Therapy Discontinuation, Bleeding, and Thromboembolic Events in Patients With Cancer During the Last Phase of Life: Insights From Primary Care Records. [PDF]

open access: yesAnn Fam Med
Abbel D   +20 more
europepmc   +1 more source

Genetic Contribution to Asthma Informs Acute Chest Syndrome Pathophysiology and Risk Stratification

open access: yesAmerican Journal of Hematology, Volume 101, Issue 5, Page 961-971, May 2026.
ABSTRACT Acute chest syndrome (ACS) is a severe complication of sickle cell disease (SCD) occurring in ~50% of patients, some presenting frequent episodes. We lack tools to identify patients at high risk of ACS occurrence or frequent episodes. Epidemiological studies have found an association between asthma and ACS, but whether this link is causal is ...
Sara El Aouhel   +10 more
wiley   +1 more source

Per‐ and Polyfluoroalkyl Substances and Hand Osteoarthritis: Data From the Osteoarthritis Initiative

open access: yesArthritis &Rheumatology, Volume 78, Issue 5, Page 1076-1087, May 2026.
Objective To explore whether biologic levels of specific per‐ and polyfluoroalkyl substances (PFAS) and a mixture of PFAS—reflecting the overall effect and accounting for correlations among PFAS—relate to incident hand osteoarthritis (HOA) and progression.
Jeffrey B. Driban   +14 more
wiley   +1 more source

Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral Neuropathy. [PDF]

open access: yesEur J Neurol
Jaubert P   +36 more
europepmc   +1 more source

Digital transformation and the Immunization agenda 2030. [PDF]

open access: yesBull World Health Organ
Chopra M   +8 more
europepmc   +1 more source

DP Politiques publiques et développement rural en Amérique Latine (DP PP-AL). Rapport d'activité 2014. Demande 2015. Socle et actions incitatives (Dispositif de recherche et d'enseignement en partenariat). Action incitative n°6

open access: green, 2014
Éric Sabourin   +16 more
openalex   +1 more source

Home - About - Disclaimer - Privacy